NCT05093400View on ClinicalTrials.gov

Oropharynx (OPX) Salivary Biomarker Study

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

May 2, 2023

Study Completion Date

May 5, 2023

Conditions
Healthy
Interventions
OTHER

no intervention

saliva collection

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05093400 - Oropharynx (OPX) Salivary Biomarker Study | Biotech Hunter | Biotech Hunter